Jim Sesic
Seminars
Thursday 4th December 2025
Panel Discussion: Evaluating the Future of Autologous & Allogeneic Therapies
11:30 am
- Evaluating the autologous and allogeneic cell therapy space
- Identify the optimal approach to maximize therapeutic efficacy
- Consider patient safety by addressing challenges related to rejection and adverse immune responses in both autologous and allogeneic therapies
- Evaluate if autologous or allogeneic therapies are best for future autoimmune therapy personalization
Thursday 4th December 2025
Panel Discussion: Discussing the Latest on the Need for Lymphodepletion in Cell Therapies to Improve Patient Access & Limit Therapeutic Side Effects
9:00 am
- Identify why lymphodepletion has been used in autoimmune cell therapies
- Examine the impact of lymphodepletion on patient recruitment and accessibility
- Consider the advantages and opportunities to remove preconditioning from therapies
Thursday 4th December 2025
Overcoming Translational Roadblocks to Accelerate Allogeneic Therapies to Clinic
12:15 pm
- Identify current roadblocks in the progression of allogeneic therapies to clinic
- Share actionable strategies to overcome translational and regulatory hurdles
- Highlight Atara Biotherapeutics’ ATA3219 targeting lupus to inform the next steps toward market readiness
